Tuesday, August 17, 2021

Governments for Pfizer

Ehdan Biber, an information-security expert, discovered a Pfizer confidential government contract on an Albanian website that is so heavily biased that it literally converts governments into agents of Pfizer.

Biber wrote that Ivermectin, an anti-parasite medicine that has been used successfully in several countries against COVID, was suppressed because the Pfizer contract requires that, even if a drug is found to treat COVID-19 effectively, the contract to continue buying products from Pfizer cannot be voided.

The contract requires governments to commit to paying for the products even if they are not shipped on time, and no products may be returned. Governments must acknowledge that the effectiveness and potential adverse effects and injuries are unknown.

The contract is written to supersede any local law of the state. It stipulates that the “‘Purchaser (meaning the government) hereby agrees to indemnify, DEFEND AND HOLD HARMLESS Pfizer, BioNTech (and) their Affiliates…from and against any and all suits, claims, actions, demands, losses, damages, liabilities, settlements, penalties, fines, costs and expenses…’

The contract says that there is no limit to the immunity from prosecution bestowed upon Pfizer even if the company commits fraud. Finally, if the purchasing government fails to enforce these defenses on behalf of Pfizer, a court in New York has the authority and capacity to take the physical assets of that country and transfer them to Pfizer.

One of the most stunning clauses stipulates: “If there are any laws or regulations in your country under which Pfizer could be prosecuted, you agree to CHANGE THE LAW OR REGULATION to close that off.” -GEG

Link for video:   https://rumble.com/vkgcq3-theres-good-reason-pfizer-fought-to-hide-the-details-of-these-contracts.html

Unredacted contracts for the experimental biological agent known as the “COVID-19 vaccine” between the Pfizer corporation and various governments continue to be revealed.

No comments:

Post a Comment